from Health Economics and Decision Science Blog @ ScHARR at https://bit.ly/3IlQLUU on February 25, 2022 at 09:36AM
Extending the QALY beyond health – the EQ-HWB (Health and well-being)
Professor John Brazier
Join the live session by clicking the link below
Measures for estimating Quality Adjusted Life Years (QALYs) (e.g. EQ-5D, SF-6D) attempt to capture the health of patients but miss broader wellbeing considerations such as autonomy and relationships that are important to patients and users of social care. Furthermore these measures do not consider the impact on carers’ quality of life. This limitation of existing measures led to the joint MRC and Euroqol Research Foundation funded Extending the QALY (E-QALY) project.
On behalf of the E-QALY team, John Brazier will describe the idea for a new and broader measure of health and wellbeing (i.e. why it was needed) for use in health and social care, some of the conceptual issues encountered and how they were approached in a large international programme of work. He will also present the mixed methods empirical work to develop the new measure called the EQ Health and WellbeingTM (EQ-HWB). Please come along and join in the discussion about the empirical research and the policy questions this new measure raises.
John Brazier is a Professor of Health Economics in the School of Health and Related Research (ScHARR) at the University of Sheffield. He was the first Director of the Economic Evaluation Policy Research Unit (EEPRU) which is a joint Sheffield and York Unit funded by the Department of Health in England to undertake applied and methodological research to inform health policy in England. Professor Brazier is currently a NIHR Senior Investigator (Emeritus).
Professor Brazier has more than 25 years’ experience of conducting economic evaluations of health care interventions for policy makers and has published over 200 peered reviewed papers. His special interest is in the measurement and valuation of health for economic evaluation where he has published widely.
Perhaps best known for his work in developing a preference-based measure of health for the SF-36 (SF-6D), but with colleagues he has further developed and extended these methods to a number of specific condition including measures in asthma, cancer, overactive bladder, diabetes, mental health, dementia and epilepsy.
John Brazier on Twitter